Cargando…
A soluble activator that favors the ex vivo expansion of CD8(+)CD27(+) T cells
Adoptive cell therapy involves the infusion of tumor-reactive T cells into patients with cancer to provide antitumor immunity. The ex vivo expansion and differentiation of such T cells are key parameters that affect their therapeutic potential. Human T cells are presently expanded in culture through...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society for Clinical Investigation
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710272/ https://www.ncbi.nlm.nih.gov/pubmed/33208551 http://dx.doi.org/10.1172/jci.insight.141293 |